Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × OTHER × Uveal Melanoma × Clear all

Phase

Status

Completed 70 Recruiting 20 Terminated 18 Unknown 17 Active not recruiting 17 Withdrawn 5 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 55 Neoplasms 44 Colorectal Neoplasms 30 Prostatic Neoplasms 27 Lung Neoplasms 20 Carcinoma, Non-Small-Cell Lung 17 Carcinoma, Hepatocellular 14 Stomach Neoplasms 12 Uterine Cervical Neoplasms 11 Anxiety Disorders 11 Lymphoma, Follicular 10 Brain Neoplasms 10 Pancreatic Neoplasms 9 Motor Activity 8 Colonic Neoplasms 8 Cholangiocarcinoma 8 Barrett Esophagus 8 Urinary Bladder Neoplasms 7 Rectal Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Sarcoma 6 Ovarian Neoplasms 6 Leukemia, Myeloid, Acute 6 Head and Neck Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Depression 6 Thyroid Diseases 5 Recurrence 5 Pain 5

Interventions

Ruthenium-106 1 Radiotherapy 1 Melphalan 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡